000 01543 a2200373 4500
005 20250515221511.0
264 0 _c20100519
008 201005s 0 0 rus d
022 _a0869-2092
040 _aNLM
_beng
_cNLM
100 1 _aDavydova, A I
245 0 0 _a[Neurochemical study of effects of the new anxiolytic drugs afobazol and ladasten on the synthesis and metabolism of monoamines and their metabolites in the brain structures of Wistar rat on the model of monoamine synthesis blockade induced by aromatic amino acid decarboxylase inhibitor NSD-1015].
_h[electronic resource]
260 _bEksperimental'naia i klinicheskaia farmakologiia
_cMar 2010
300 _a2-6 p.
_bdigital
500 _aPublication Type: English Abstract; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdamantane
_xanalogs & derivatives
650 0 4 _aAnimals
650 0 4 _aAnti-Anxiety Agents
_xpharmacology
650 0 4 _aAromatic Amino Acid Decarboxylase Inhibitors
650 0 4 _aBenzimidazoles
_xpharmacology
650 0 4 _aBiogenic Monoamines
_xantagonists & inhibitors
650 0 4 _aBrain
_xdrug effects
650 0 4 _aChromatography, High Pressure Liquid
650 0 4 _aHydrazines
_xpharmacology
650 0 4 _aMale
650 0 4 _aMorpholines
_xpharmacology
650 0 4 _aRats
650 0 4 _aRats, Wistar
700 1 _aKlodt, P M
700 1 _aKudrin, V S
700 1 _aKuznetsova, E A
700 1 _aNarkevich, V B
773 0 _tEksperimental'naia i klinicheskaia farmakologiia
_gvol. 73
_gno. 3
_gp. 2-6
999 _c19766210
_d19766210